Infection Control Market Size, Share, Trends Analysis, 2032

Infection Control Market

Infection Control Market By Product Type (Disinfection Products, Sterilization Products and Services, and Others), By Sterilization (Heat Sterilization, Low Temperature Sterilization, Filtration Methodologies, and Others), By End-User (Pharmaceutical, Life Sciences, Medical Devices, and Food Industries), and By Region: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024-2032

Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-1571 Published Date: Jun-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 53.15 Billion USD 94.47 Billion 6.6% 2023

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global infection control market, 2024-2032 (USD Billion)
    • 2.2. Global infection control market: snapshot
  •  
  • Chapter 3. Infection Control Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Global infection control market drivers: impact analysis
      • 3.2.2. High incidences of hospital-acquired infections
      • 3.2.3. An increasing number of surgical procedures
      • 3.2.4. Growing focus on food sterilization and disinfection
    • 3.3. Market Restraints
      • 3.3.1. Global infection control market restraints: impact analysis
      • 3.3.2. Concerns regarding the safety of reprocessed instruments
      • 3.3.3. End-user noncompliance with sterilization standards
    • 3.4. Opportunities
      • 3.4.1. Growing medical device and pharmaceutical industries in emerging economies
      • 3.4.2. Increasing use of e-beam sterilization
      • 3.4.3. The rising importance of single-use medical nonwovens and medical devices
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis, by product type
      • 3.6.2. Market attractiveness analysis, by sterilization
      • 3.6.3. Market attractiveness analysis, by end-user
      • 3.6.4. Market attractiveness analysis, by region
  •  
  • Chapter 4. Global Infection Control Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global infection control market: company market share, 2024
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New therapy launch
      • 4.2.3. Agreements, partnerships, collaborations, and joint ventures
      • 4.2.4. Research and development and regional expansion
    • 4.3. Price trend analysis
  •  
  • Chapter 5. Global Infection Control Market - Product Type Analysis
    • 5.1. Global infection control market: product type overview
      • 5.1.1. Global infection control market revenue share, by product type, 2024 and 2032
    • 5.2. Sterilization Products and Services
      • 5.2.1. Global infection control market for sterilization products and services, 2024-2032 (USD Billion)
    • 5.3. Disinfection Products
      • 5.3.1. Global infection control market for disinfection products, 2024-2032 (USD Billion)
    • 5.4. Others
      • 5.4.1. Global infection control market for others, 2024-2032 (USD Billion)
  •  
  • Chapter 6. Global Infection Control Market - Sterilization Analysis
    • 6.1. Global infection control market: sterilization overview
      • 6.1.1. Global infection control market revenue share, by sterilization, 2024 and 2032
    • 6.2. Heat Sterilization
      • 6.2.1. Global infection control market for heat sterilization, 2024-2032 (USD Billion)
    • 6.3. Filtration Methodologies
      • 6.3.1. Global infection control market for filtration methodologies, 2024-2032 (USD Billion)
    • 6.4. Low-Temperature Sterilization
      • 6.4.1. Global infection control market for low-temperature sterilization, 2024-2032 (USD Billion)
    • 6.5. Others
      • 6.5.1. Global infection control market for others, 2024-2032 (USD Billion)
  •  
  • Chapter 7. Global Infection Control Market - End-User Analysis
    • 7.1. Global infection control market: end-user overview
      • 7.1.1. Global infection control market revenue share, by end-user, 2024 and 2032
    • 7.2. Life Sciences
      • 7.2.1. Global infection control market for hospitals, 2024-2032 (USD Billion)
    • 7.3. Pharmaceutical
      • 7.3.1. Global infection control market for pharmaceutical, 2024-2032 (USD Billion)
    • 7.4. Food Industries
      • 7.4.1. Global infection control market for food industries, 2024-2032 (USD Billion)
    • 7.5. Medical Devices
      • 7.5.1. Global infection control market for medical devices, 2024-2032 (USD Billion)
  •  
  • Chapter 8. Global Infection Control Market - Regional Analysis
    • 8.1. Global infection control market: regional overview
      • 8.1.1. Global infection control market revenue share, by region, 2024 and 2032
    • 8.2. North America
      • 8.2.1. North America infection control market revenue, by product type, 2024-2032 (USD Billion)
      • 8.2.2. North America infection control market revenue, by sterilization, 2024-2032 (USD Billion)
      • 8.2.3. North America infection control market revenue, by end-user, 2024-2032 (USD Billion)
      • 8.2.4. The U.S.
        • 8.2.4.1. The U.S. infection control market revenue, by product type, 2024-2032 (USD Billion)
        • 8.2.4.2. The U.S. infection control market revenue, by sterilization, 2024-2032 (USD Billion)
        • 8.2.4.3. The U.S. infection control market revenue, by end-user, 2024-2032 (USD Billion)
      • 8.2.5. Canada
        • 8.2.5.1. Canada infection control market revenue, by product type, 2024-2032 (USD Billion)
        • 8.2.5.2. Canada infection control market revenue, by sterilization, 2024-2032 (USD Billion)
        • 8.2.5.3. Canada infection control market revenue, by end-user, 2024-2032 (USD Billion)
    • 8.3. Europe
      • 8.3.1. Europe infection control market revenue, by product type, 2024-2032 (USD Billion)
      • 8.3.2. Europe infection control market revenue, by sterilization, 2024-2032 (USD Billion)
      • 8.3.3. Europe infection control market revenue, by end-user, 2024-2032 (USD Billion)
      • 8.3.4. U.K.
        • 8.3.4.1. U.K. infection control market revenue, by product type, 2024-2032 (USD Billion)
        • 8.3.4.2. U.K. infection control market revenue, by sterilization, 2024-2032 (USD Billion)
        • 8.3.4.3. U.K. infection control market revenue, by end-user, 2024-2032 (USD Billion)
      • 8.3.5. Germany
        • 8.3.5.1. Germany infection control market revenue, by product type, 2024-2032 (USD Billion)
        • 8.3.5.2. Germany infection control market revenue, by sterilization, 2024-2032 (USD Billion)
        • 8.3.5.3. Germany infection control market revenue, by end-user, 2024-2032 (USD Billion)
      • 8.3.6. France
        • 8.3.6.1. France infection control market revenue, by product type, 2024-2032 (USD Billion)
        • 8.3.6.2. France infection control market revenue, by sterilization, 2024-2032 (USD Billion)
        • 8.3.6.3. France infection control market revenue, by end-user, 2024-2032 (USD Billion)
      • 8.3.7. Rest of Europe
        • 8.3.7.1. Rest of Europe infection control market revenue, by product type, 2024-2032 (USD Billion)
        • 8.3.7.2. Rest of Europe infection control market revenue, by sterilization, 2024-2032 (USD Billion)
        • 8.3.7.3. Rest of Europe infection control market revenue, by end-user, 2024-2032 (USD Billion)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific infection control market revenue, by product type, 2024-2032 (USD Billion)
      • 8.4.2. Asia Pacific infection control market revenue, by sterilization, 2024-2032 (USD Billion)
      • 8.4.3. Asia Pacific infection control market revenue, by end-user, 2024-2032 (USD Billion)
      • 8.4.4. China
        • 8.4.4.1. China infection control market revenue, by product type, 2024-2032 (USD Billion)
        • 8.4.4.2. China infection control market revenue, by sterilization, 2024-2032 (USD Billion)
        • 8.4.4.3. China infection control market revenue, by end-user, 2024-2032 (USD Billion)
      • 8.4.5. Japan
        • 8.4.5.1. Japan infection control market revenue, by product type, 2024-2032 (USD Billion)
        • 8.4.5.2. Japan infection control market revenue, by sterilization, 2024-2032 (USD Billion)
        • 8.4.5.3. Japan infection control market revenue, by end-user, 2024-2032 (USD Billion)
      • 8.4.6. India
        • 8.4.6.1. India infection control market revenue, by product type, 2024-2032 (USD Billion)
        • 8.4.6.2. India infection control market revenue, by sterilization, 2024-2032 (USD Billion)
        • 8.4.6.3. India infection control market revenue, by end-user, 2024-2032 (USD Billion)
      • 8.4.7. Rest of Asia Pacific
        • 8.4.7.1. Rest of Asia Pacific infection control market revenue, by product type, 2024-2032 (USD Billion)
        • 8.4.7.2. Rest of Asia Pacific infection control market revenue, by sterilization, 2024-2032 (USD Billion)
        • 8.4.7.3. Rest of Asia Pacific infection control market revenue, by end-user, 2024-2032 (USD Billion)
    • 8.5. Latin America
      • 8.5.1. Latin America infection control market revenue, by product type, 2024-2032 (USD Billion)
      • 8.5.2. Latin America infection control market revenue, by sterilization, 2024-2032 (USD Billion)
      • 8.5.3. Latin America infection control market revenue, by end-user, 2024-2032 (USD Billion)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil infection control market revenue, by product type, 2024-2032 (USD Billion)
        • 8.5.4.2. Brazil infection control market revenue, by sterilization, 2024-2032 (USD Billion)
        • 8.5.4.3. Brazil infection control market revenue, by end-user, 2024-2032 (USD Billion)
      • 8.5.5. Rest of Latin America
        • 8.5.5.1. Rest of Latin America infection control market revenue, by product type, 2024-2032 (USD Billion)
        • 8.5.5.2. Rest of Latin America infection control market revenue, by sterilization, 2024-2032 (USD Billion)
        • 8.5.5.3. Rest of Latin America infection control market revenue, by end-user, 2024-2032 (USD Billion)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa infection control market revenue, by product type, 2024-2032 (USD Billion)
      • 8.6.2. The Middle East and Africa infection control market revenue, by sterilization, 2024-2032 (USD Billion)
      • 8.6.3. The Middle East and Africa infection control market revenue, by end-user, 2024-2032 (USD Billion)
  •  
  • Chapter 9. Company Profile
    • 9.1. Getinge
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. Advanced Sterilization Products
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. Sotera Health
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. STERIS
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. 3M
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. Belimed
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. Cantel Medical Corporation
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. Reckitt Benckiser Group
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments
    • 9.9. Matachana Group
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product portfolio
      • 9.9.4. Business strategy
      • 9.9.5. Recent developments
    • 9.10. Ecolab
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product portfolio
      • 9.10.4. Business strategy
      • 9.10.5. Recent developments
    • 9.11. MMM Group
      • 9.11.1. Overview
      • 9.11.2. Financials
      • 9.11.3. Product portfolio
      • 9.11.4. Business strategy
      • 9.11.5. Recent developments
    • 9.12. Metrex Research Corporation
      • 9.12.1. Overview
      • 9.12.2. Financials
      • 9.12.3. Product portfolio
      • 9.12.4. Business strategy
      • 9.12.5. Recent developments
    • 9.13. Miele Group
      • 9.13.1. Overview
      • 9.13.2. Financials
      • 9.13.3. Product portfolio
      • 9.13.4. Business strategy
      • 9.13.5. Recent developments
    • 9.14. Melag
      • 9.14.1. Overview
      • 9.14.2. Financials
      • 9.14.3. Product portfolio
      • 9.14.4. Business strategy
      • 9.14.5. Recent developments
    • 9.15. Pal International
      • 9.15.1. Overview
      • 9.15.2. Financials
      • 9.15.3. Product portfolio
      • 9.15.4. Business strategy
      • 9.15.5. Recent developments

Table Of Figures

List of Figures

1. Market research process
2. Market methodology
3. Global infection control market revenue, 2024–2032 (USD Billion) 
4. Porter’s Five Forces Analysis
5. Infection control market attractiveness analysis, by product type
6. Infection control market attractiveness analysis, by sterilization
7. Infection control market attractiveness analysis, by end-user
8. Infection control market attractiveness analysis, by region
9. Company market share analysis, 2024 
10. Global infection control market revenue share by product type, 2024 and 2032
11. Global infection control market for sterilization products and services, 2024–2032 (USD Billion)
12. Global infection control market for disinfection products, 2024–2032 (USD Billion)
13. Global infection control market for others, 2024–2032 (USD Billion)
14. Global infection control market revenue share by sterilization, 2024 and 2032
15. Global infection control market for heat sterilization, 2024–2032 (USD Billion)
16. Global infection control market for filtration methodologies, 2024–2032 (USD Billion)
17. Global infection control market for low-temperature sterilization, 2024–2032 (USD Billion)
18. Global infection control market for others, 2024–2032 (USD Billion)
19. Global infection control market revenue share by end-user, 2024 and 2032
20. Global infection control market for life sciences, 2024–2032 (USD Billion)
21. Global infection control market for pharmaceutical, 2024–2032 (USD Billion)
22. Global infection control market for food industries, 2024–2032 (USD Billion)
23. Global infection control market for medical devices, 2024–2032 (USD Billion)
24. Global infection control market revenue share by region, 2024 and 2032
25. North America infection control market, 2024–2032 (USD Billion)
26. Europe infection control market, 2024–2032 (USD Billion)
27. Asia Pacific infection control market, 2024–2032 (USD Billion)
28. Latin America infection control market, 2024–2032 (USD Billion)
29. The Middle East and Africa infection control market, 2024–2032 (USD Billion)


Table Of Tables

List of Tables

1. Infection Control market: market snapshot  
2. Drivers of the global infection control market: impact analysis
3. Restraints of the global infection control market: impact analysis
4. North America infection control market revenue, by product type, 2024–2032 (USD Billion)
5. North America infection control market revenue, by sterilization, 2024–2032 (USD Billion)
6. North America infection control market revenue, by end-user, 2024–2032 (USD Billion)
7. The U.S. infection control market revenue, by product type, 2024–2032 (USD Billion)
8. The U.S. infection control market revenue, by sterilization, 2024–2032 (USD Billion)
9. The U.S. infection control market revenue, by end-user, 2024–2032 (USD Billion)
10. Canada infection control market revenue, by product type, 2024–2032 (USD Billion)
11. Canada infection control market revenue, by sterilization, 2024–2032 (USD Billion)
12. Canada infection control market revenue, by end-user, 2024–2032 (USD Billion)
13. Europe infection control market revenue, by product type, 2024–2032 (USD Billion)
14. Europe infection control market revenue, by sterilization, 2024–2032 (USD Billion)
15. Europe infection control market revenue, by end-user, 2024–2032 (USD Billion)
16. U.K. infection control market revenue, by product type, 2024–2032 (USD Billion)
17. U.K. infection control market revenue, by sterilization, 2024–2032 (USD Billion)
18. U.K. infection control market revenue, by end-user, 2024–2032 (USD Billion)
19. Germany infection control market revenue, by product type, 2024–2032 (USD Billion)
20. Germany infection control market revenue, by sterilization, 2024–2032 (USD Billion)
21. Germany infection control market revenue, by end-user, 2024–2032 (USD Billion)
22. France infection control market revenue, by product type, 2024–2032 (USD Billion)
23. France infection control market revenue, by sterilization, 2024–2032 (USD Billion)
24. France infection control market revenue, by end-user, 2024–2032 (USD Billion)
25. Rest of Europe infection control market revenue, by product type, 2024–2032 (USD Billion) 
26. Rest of Europe infection control market revenue, by sterilization, 2024–2032 (USD Billion)
27. Rest of Europe infection control market revenue, by end-user, 2024–2032 (USD Billion)
28. Asia Pacific infection control market revenue, by product type, 2024–2032 (USD Billion)
29. Asia Pacific infection control market revenue, by sterilization, 2024–2032 (USD Billion)
30. Asia Pacific infection control market revenue, by end-user, 2024–2032 (USD Billion)
31. China infection control market revenue, by product type, 2024–2032 (USD Billion)
32. China infection control market revenue, by sterilization, 2024–2032 (USD Billion)
33. China infection control market revenue, by end-user, 2024–2032 (USD Billion)
34. Japan infection control market revenue, by product type, 2024–2032 (USD Billion)
35. Japan infection control market revenue, by sterilization, 2024–2032 (USD Billion)
36. Japan infection control market revenue, by end-user, 2024–2032 (USD Billion)
37. India infection control market revenue, by product type, 2024–2032 (USD Billion)
38. India infection control market revenue, by sterilization, 2024–2032 (USD Billion)
39. India infection control market revenue, by end-user, 2024–2032 (USD Billion)
40. Rest of Asia Pacific infection control market revenue, by product type, 2024–2032 (USD Billion)
41. Rest of Asia Pacific infection control market revenue, by sterilization, 2024–2032 (USD Billion)
42. Rest of Asia Pacific infection control market revenue, by end-user, 2024–2032 (USD Billion)
43. Latin America infection control market revenue, by product type, 2024–2032 (USD Billion)
44. Latin America infection control market revenue, by sterilization, 2024–2032 (USD Billion)
45. Latin America infection control market revenue, by end-user, 2024–2032 (USD Billion)
46. Brazil infection control market revenue, by product type, 2024–2032 (USD Billion)
47. Brazil infection control market revenue, by sterilization, 2024–2032 (USD Billion)
48. Brazil infection control market revenue, by end-user, 2024–2032 (USD Billion)
49. Rest of Latin America infection control market revenue, by product type, 2024–2032 (USD Billion)
50. Rest of Latin America infection control market revenue, by sterilization, 2024–2032 (USD Billion)
51. Rest of Latin America infection control market revenue, by end-user, 2024–2032 (USD Billion)
52. The Middle East and Africa infection control market revenue, by product type, 2024–2032 (USD Billion)
53. The Middle East and Africa infection control market revenue, by sterilization, 2024–2032 (USD Billion)
54. The Middle East and Africa infection control market revenue, by end-user, 2024–2032 (USD Billion)

Methodology

FrequentlyAsked Questions

Infection control is the practice of preventing the spread of infections. In healthcare settings, it focuses on protecting patients, healthcare workers, and visitors from harmful germs. This involves a combination of methods, including hand hygiene, sterilization, disinfection, and following specific protocols for handling patients with infectious diseases.

According to a study, the global infection control market size was worth around USD 53.15 billion in 2023 and is expected to reach USD 94.47 billion by 2032.

The global infection control market is expected to grow at a CAGR of 6.6% during the forecast period.

North America is expected to dominate the infection control market over the forecast period.

Leading players in the global infection control market include Getinge, Advanced Sterilization Products, Sotera Health, STERIS, 3M, Belimed, Cantel Medical Corporation, Reckitt Benckiser Group, Matachana Group, Ecolab, MMM Group, Metrex Research Corporation, Miele Group, Melag, and Pal International, among others.

The infection control market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTLE analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five forces analysis, and value chain analysis.

  • zion payment modes

List of Contents

infection control Industry PerspectiveOverviewGrowth FactorsSegmentationReport ScopeRegional AnalysisCompetitive AnalysisThe Global Market is segmented as follows:

HappyClients